Previously, we reported that TES promoter methylation was a common event across all subtypes of childhood acute lymphoblastic leukaemia (ALL) and that dense, biallelic methylation of the TES promoter results in loss of transcription and absence of TESTIN protein9. The gene discussed is TES; the disease is acute lymphoblastic leukemia.